Fig. 3From: Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort studyKaplan-Meier survival curves of in-hospital death among patients in whom treatment with ARBs was continued as compared to those in whom ACEIs was continued (defined in the first 3-day window). Abbreviations: ACEIs angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers. *Log-rank testBack to article page